Author

Theo Pirich

Institution: Karl Landsteiner University of Health Sciences

Observed institutions: Universitätsklinikum Krems, Karl Landsteiner University of Health Sciences

OpenAlex ID: A5082583249

Favorable impact of PD1/PD-L1 antagonists on bone remodeling: an exploratory prospective clinical study and ex vivo validation

2024 · Tamara Gassner, Christina Chittilappilly, et al. · Journal for ImmunoTherapy of Cancer · 17

Tolerability of obinutuzumab therapy in patients with rituximab-relapsed/refractory B-cell malignancies - a retrospective single center cohort study

2018 · Theo Pirich, Elisabeth Zwickl-Traxler, et al. · Oncotarget · 9

1255 Impact of immune checkpoint inhibitors on bone turnover in cancer patients: prospective clinical study and preclinical correlates

2022 · Tamara Gassner, Sonia Vallet, et al. · Journal for ImmunoTherapy of Cancer · 1

Works count: 3

Citation count: 27

H-index: 2

I10-index: 1